These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 38340190)
1. The combined anti-tumor effects of 5-fluorouracil and neurokinin receptor inhibitor, aprepitant, against colorectal cancer: In vitro and in vivo study. Alalikhan A; Ebrahimi S; Aliee A; Mirzavi F; Hashemy SI Med Oncol; 2024 Feb; 41(3):70. PubMed ID: 38340190 [TBL] [Abstract][Full Text] [Related]
2. Tenacissoside G synergistically potentiates inhibitory effects of 5-fluorouracil to human colorectal cancer. Wang K; Liu W; Xu Q; Gu C; Hu D Phytomedicine; 2021 Jun; 86():153553. PubMed ID: 33906076 [TBL] [Abstract][Full Text] [Related]
3. EIF3D promotes resistance to 5-fluorouracil in colorectal cancer through upregulating RUVBL1. Li C; Lu K; Yang C; Du W; Liang Z J Clin Lab Anal; 2023 Jan; 37(2):e24825. PubMed ID: 36592991 [TBL] [Abstract][Full Text] [Related]
4. Investigation of the Role of Neurokinin-1 Receptor Inhibition Using Aprepitant in the Apoptotic Cell Death through PI3K/Akt/NF- Ghahremanloo A; Javid H; Afshari AR; Hashemy SI Biomed Res Int; 2021; 2021():1383878. PubMed ID: 34395609 [TBL] [Abstract][Full Text] [Related]
5. Synergistic antitumor effect of 5-fluorouracil in combination with parthenolide in human colorectal cancer. Kim SL; Kim SH; Trang KT; Kim IH; Lee SO; Lee ST; Kim DG; Kang SB; Kim SW Cancer Lett; 2013 Jul; 335(2):479-86. PubMed ID: 23507557 [TBL] [Abstract][Full Text] [Related]
6. Gypenosides Synergistically Enhances the Anti-Tumor Effect of 5-Fluorouracil on Colorectal Cancer In Vitro and In Vivo: A Role for Oxidative Stress-Mediated DNA Damage and p53 Activation. Kong L; Wang X; Zhang K; Yuan W; Yang Q; Fan J; Wang P; Liu Q PLoS One; 2015; 10(9):e0137888. PubMed ID: 26368019 [TBL] [Abstract][Full Text] [Related]
7. Icariin-mediated inhibition of NF-κB activity enhances the in vitro and in vivo antitumour effect of 5-fluorouracil in colorectal cancer. Shi DB; Li XX; Zheng HT; Li DW; Cai GX; Peng JJ; Gu WL; Guan ZQ; Xu Y; Cai SJ Cell Biochem Biophys; 2014 Jul; 69(3):523-30. PubMed ID: 24435883 [TBL] [Abstract][Full Text] [Related]
8. Metformin Inhibited Proliferation and Metastasis of Colorectal Cancer and presented a Synergistic Effect on 5-FU. Sang J; Tang R; Yang M; Sun Q Biomed Res Int; 2020; 2020():9312149. PubMed ID: 32851092 [TBL] [Abstract][Full Text] [Related]
9. Low curcumin concentration enhances the anticancer effect of 5-fluorouracil against colorectal cancer. Zheng X; Yang X; Lin J; Song F; Shao Y Phytomedicine; 2021 May; 85():153547. PubMed ID: 33812170 [TBL] [Abstract][Full Text] [Related]
10. Vactosertib potently improves anti-tumor properties of 5-FU for colon cancer. Binabaj MM; Asgharzadeh F; Rahmani F; Al-Asady AM; Hashemzehi M; Soleimani A; Avan A; Mehraban S; Ghorbani E; Ryzhikov M; Khazaei M; Hassanian SM Daru; 2023 Dec; 31(2):193-203. PubMed ID: 37740873 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of the Wnt/b-catenin pathway using PNU-74654 reduces tumor growth in in vitro and in vivo models of colorectal cancer. Amerizadeh F; Rahmani F; Maftooh M; Nasiri SN; Hassanian SM; Giovannetti E; Moradi-Marjaneh R; Sabbaghzadeh R; Shahidsales S; Joudi-Mashhad M; Ghayour-Mobarhan M; Ferns GA; Khazaei M; Avan A Tissue Cell; 2022 Aug; 77():101853. PubMed ID: 35803035 [TBL] [Abstract][Full Text] [Related]
12. Synergistic antitumor activity of 5-fluorouracil and atosiban against microsatellite stable colorectal cancer through restoring GATA3. Wang M; Guo X; Yang M; Zhang Y; Meng F; Chen Y; Chen M; Qiu T; Li J; Li Z; Zhang Q; Xu F; Zhang H; Wang W Biochem Pharmacol; 2022 May; 199():115025. PubMed ID: 35367196 [TBL] [Abstract][Full Text] [Related]
13. Down-regulating IL-6/GP130 targets improved the anti-tumor effects of 5-fluorouracil in colon cancer. Li S; Tian J; Zhang H; Zhou S; Wang X; Zhang L; Yang J; Zhang Z; Ji Z Apoptosis; 2018 Jun; 23(5-6):356-374. PubMed ID: 29777330 [TBL] [Abstract][Full Text] [Related]
14. Enhanced anti-colorectal cancer effects of carfilzomib combined with CPT-11 via downregulation of nuclear factor-κB in vitro and in vivo. Tang W; Su G; Li J; Liao J; Chen S; Huang C; Liu F; Chen Q; Ye Y Int J Oncol; 2014 Sep; 45(3):995-1010. PubMed ID: 24968890 [TBL] [Abstract][Full Text] [Related]
15. The in vitro anti-cancer synergy of neurokinin-1 receptor antagonist, aprepitant, and 5-aminolevulinic acid in glioblastoma. Ebrahimi S; Mirzavi F; Hashemy SI; Khaleghi Ghadiri M; Stummer W; Gorji A Biofactors; 2023; 49(4):900-911. PubMed ID: 37092793 [TBL] [Abstract][Full Text] [Related]
16. Co-delivery of 5-fluorouracil and miRNA-34a mimics by host-guest self-assembly nanocarriers for efficacious targeted therapy in colorectal cancer patient-derived tumor xenografts. Xu J; Zhang G; Luo X; Wang D; Zhou W; Zhang Y; Zhang W; Chen J; Meng Q; Chen E; Chen H; Song Z Theranostics; 2021; 11(5):2475-2489. PubMed ID: 33500737 [No Abstract] [Full Text] [Related]
17. Synergistic antitumor effect of dichloroacetate in combination with 5-fluorouracil in colorectal cancer. Tong J; Xie G; He J; Li J; Pan F; Liang H J Biomed Biotechnol; 2011; 2011():740564. PubMed ID: 21403907 [TBL] [Abstract][Full Text] [Related]
18. Esculetin enhances the inhibitory effect of 5-Fluorouracil on the proliferation, migration and epithelial-mesenchymal transition of colorectal cancer. Yan L; Yu HH; Liu YS; Wang YS; Zhao WH Cancer Biomark; 2019; 24(2):231-240. PubMed ID: 30689555 [TBL] [Abstract][Full Text] [Related]
19. Synergistic antitumor effect of 3-bromopyruvate and 5-fluorouracil against human colorectal cancer through cell cycle arrest and induction of apoptosis. Chong D; Ma L; Liu F; Zhang Z; Zhao S; Huo Q; Zhang P; Zheng H; Liu H Anticancer Drugs; 2017 Sep; 28(8):831-840. PubMed ID: 28816773 [TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of BIRC7/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC, MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or without aspirin. Faruk M; Ibrahim S; Aminu SM; Adamu A; Abdullahi A; Suleiman AM; Rafindadi AH; Mohammed A; Iliyasu Y; Idoko J; Saidu R; Randawa AJ; Musa HS; Ntekim A; Shah KZ; Abubakar S; Adoke KU; Manko M; Awasum CA PLoS One; 2021; 16(1):e0245581. PubMed ID: 33465114 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]